CRNX - Crinetics Pharmaceuticals, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
44.97 -0.83 (-1.85%) --- --- --- 0.53 (1.18%) -0.1 (-0.23%) --- 0.53 (1.18%)

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-1.23
Diluted EPS:
-1.23
Basic P/E:
-35.8862
Diluted P/E:
-35.8862
RSI(14) 1m:
33.33
VWAP:
44.15
RVol:
0.4003

Events

Period Kind Movement Occurred At
1m Price increase 1m 45.75 +0.78 (+1.73%) Oct 15 08:29

Related News